Subscribe   RSS Contact Us

Coalition Calls for Substantial Revisions to Sunshine Act Proposed Rules

Feb. 16, 2012 – Further notice and comment are necessary for the implementation of Section 6002 of the Affordable Care ... read more

Refuting Inaccurate CER Results Is “Right” of Drug Sponsors, Temple Says

Feb. 13, 2012 – Dr. Robert Temple, the unofficial dean of drugs at the FDA, recently addressed one of the ... read more

Digital Health Coalition Issues Guiding Principles and Best Practices to Help Lead Way on Robust Use of Social Media by Medicine Companies

Feb. 7, 2012 – Responding to patient and professional calls for more industry participation in the Internet and social media, ... read more

Drug Facts Literature Review: Call for Comments

Feb. 3, 2012 – There are just 10 days left to comment on an FDA draft report that explores the ... read more

House Health Subcommittee PDUFA V Hearing Yields Little Talk of Marketing – For Now

Feb. 2, 2012 – More than four hours of testimony before the House Energy and Commerce Committee’s Subcommittee on Health ... read more

Digital Advertising Alliance Launches Consumer Education Campaign

Jan. 27, 2012 – The Digital Advertising Alliance (DAA) last week launched its “Your AdChoices” public education campaign to inform ... read more

MMM: CME Video Addresses Conflict of Interest

Jan. 26, 2012 – Avoiding conflict of interest in continuing medical education (CME) may seem like a daunting task, but ... read more

Does Novo Nordisk’s Victoza + Paula Deen = Recipe for Success?

Jan. 20, 2012 – Common sense should tell people that some of celebrity chef Paula Deen’s infamously unhealthy dishes – ... read more

Sunshine or Rain?

By Jack E. Angel, Education Foundation Executive Director, Coalition for Healthcare Communication Jan. 17, 2012 – The Affordable Care Act ... read more

MMM Features Kamp’s Call for Industry Leadership on Off-label, Online Communications

 Jan. 6, 2012 — This article, written by Coalition for Healthcare Communication Executive Director John Kamp, was featured in the ... read more

OPDP to Industry: Voluntary Compliance Efforts in New Year Can Prevent Same Old Violations

Jan. 6, 2011 – As the pharmaceutical industry begins 2012, the FDA’s Office of Prescription Drug Promotion (OPDP) recommends that ... read more

FDA Issues Draft Guidance on Unsolicited Off-label Info Requests, Addresses both Professional and Internet Media

Jan. 2, 2012 – In the waning days of 2011, the FDA released a significant draft guidance on company responses to ... read more

Finally, CMS Issues Sunshine Act Proposed Rule and Resets Compliance Deadlines

Dec. 15, 2011 – The Centers for Medicare & Medicaid Services (CMS) issued its long-awaited Proposed Rule for implementing the Physician ... read more

MMM Previews Pharma Debates in DC: Prepare for a Wild Ride in 2012

Dec. 12, 2011 — Facing a need to decrease spending and boost revenues, the federal government will continue to target ... read more

Government, Industry and Educators Are Called to Action on a Looming Health Crisis

  By Jack E. Angel, Education Foundation Executive Director, Coalition for Healthcare Communication Nov. 14, 2011 — In response to ... read more

FDA Approval Report Contains Good News for Patients and Industry

  By John Kamp, Executive Director, Coalition for Healthcare Communication – Nov. 7, 2011 – Until the research labs and ... read more

RPM Report: Pandora’s Box Officially Open as New Legal Challenges to FDA’s Off-label Restrictions Emerge

Oct. 24, 2011 – After the U.S. Supreme Court struck down speaker- and content-based restrictions in Sorrell v. IMS Health, ... read more

Par Pharma Case Asserts That First Amendment Protects Truthful Off-label Speech

Oct. 18, 2011 – A case filed by Par Pharmaceutical, Inc. against the FDA seeks to preserve Par’s First Amendment ... read more

Kamp on the Sunshine Act: Collaboration Key to Patient Care

Dec. 14, 2011 — UPDATE — CMS has published the proposed rules enforcing the Sunshine provisions of the Affordable Care ... read more

Fall 2011 Update: Four Things Industry Should Know

  By John Kamp, Coalition for Healthcare Communication Executive Director Sept. 13, 2011 — Debates over health care and related ... read more

Experts Weigh In on Implications of Sorrell Decision

Aug. 1, 2011 — The recent Supreme Court decision in Sorrell v. IMS Health Inc. is earning robust commentary in ... read more

Academic Detailing and Health Plan Communications: Is the Playing Field Level?

By Kenneth P. Berkowitz, Esq. July 21, 2011 — Why does the government fail to apply current regulatory requirements and ... read more

Sorrell v. IMS: What Marketing Professionals Need to Know

By John Kamp, Executive Director, Coalition for Healthcare Communication July 18, 2011 — For those who have not read the ... read more

Kamp Column: Industry Must Embrace Internet and Social Media or Become Irrelevant in Many Health Conversations

By John Kamp, Executive Director, Coalition for Healthcare Communication June 29, 2011 — Yesterday I had the pleasure of moderating ... read more

PhRMA Survey Shows That Physicians Value Industry Communication

March 31, 2011 — At a time when interaction between biopharmaceutical companies and physicians is under increased scrutiny, a recent ... read more

Previous Next

Resources

     

Podcasts

Sorry, there are currently no podcasts available.

Slideshows

Enforcement Webinar
Read the original post.

PDFs

Get Adobe Reader To view PDF documents, you must have
Adobe Reader installed on your computer.


Literature Review
Read the original post.

Responding to Unsolicited Requests for Off-Label Information
Read the original post.

PrevisionPolicy
Read the original post.

Sunshine Act Proposed Rule
Read the original post.

Sunshine Act Proposed Rule
Read the original post.

Detailing DC
Read the original post.

PDUFA Event Invite
Read the original post.

PDUFA Event Invite
Read the original post.

Blueprint for Prescriber CME
Read the original post.

Draft Proposals
Read the original post.

Caronia Amicus Brief
Read the original post.

attached letter
Read the original post.

Citizen Petition
Read the original post.

amicus brief
Read the original post.

FDLI Marketing Conference Agenda
Read the original post.

RxComplianceReport
Read the original post.

click here
Read the original post.

here
Read the original post.

KPB - RPM Report-9-2006
Read the original post.

10-779
Read the original post.

AEI Guest Column
Read the original post.

Social Media Legal Guide
Read the original post.

Do Not Track Kids Act of 2011
Read the original post.

Do-Not-Track Online Act of 2011
Read the original post.

April 28 Federal Register
Read the original post.

Commercial Privacy Bill of Rights Text
Read the original post.

amicus brief
Read the original post.

Do Not Track Me Online Act
Read the original post.

Best Practices Act
Read the original post.

Do Not Track Me Online Act
Read the original post.

Harvard Business Review Analytics Service Report
Read the original post.

2011 Focus of the Coalition
Read the original post.

Public Roadshow
Read the original post.

Public Roadshow
Read the original post.

Roadshow 2011
Read the original post.

IMS Health Inc. V. Sorrell Court of Appeals Decision
Read the original post.

Press Release on Patient Access to Care
Read the original post.

The Coalition's Letter to the Senate on the Focus of Patient Access to Care
Read the original post.

The Coalition's Formal Comment on FDA's "Presenting Risk Information in Prescription Drug and Medical Device Promotion"
Read the original post.

Report on Doctor and Patient Benefit From Commercially Supported CME
Read the original post.

Ad Coalition Paper on Economic Impact of Advertising in New York's 17th District
Read the original post.

Mark Marmur's December 10, 2009 Presentation on the FDA's Social Media Hearings
Read the original post.

FDA and Social Media: December 10, 2009 presentation
Read the original post.

The Coalition and AAAA's Joint FDA Social Media Testimony
Read the original post.

Study From the Cleveland Clinic on Whether CME Funding Creates Bias
Read the original post.

Press Release on ACCME's March Board of Directors Meeting
Read the original post.

The ACCME's Review Results From its March Board of Directors Meeting
Read the original post.

The Coalition's Comment on the Formation of an Independent Funding Entity
Read the original post.

The Coalition's Comment on the Banning of Qualified, Eminent Speakers and Authors
Read the original post.

The Coalition's Comment on "Commercial Free" Designation
Read the original post.

The Coalition's Comment, Urging ACCME to Post "Final Rules" for Additional Comment
Read the original post.

Comments From AACE-ACE (Endocrinologists) on AMA's CEJA Report
Read the original post.

Recommendation for CEJA Report Revision by The Alliance for Continuing Medical Education
Read the original post.

Recommendation for CEJA Report Revision by the Council on Medical Specialty Societies (CMSS)
Read the original post.

Analysis and Recommendation for CEJA Report Revision by John Kamp on Behalf of the Coalition
Read the original post.

CEJA Recommendation for Revision to its report, "Financial Relationships With Industry in Continuing Medical Education"
Read the original post.

Coalition Amici Brief Submitted to U.S. Appeals Court, Defending Marketing Use of Prescription Data and Asserting First Amendment Rights
Read the original post.

Bill Denying Tax Deduction for Drug Ads Unconstitutional
Read the original post.

List of Legislative Directors of the House Ways and Means Committees
Read the original post.

List of Legislative Directors of the Senate Finance Committees
Read the original post.

"Talking Points" and Draft Email Letters on Elimination of the Tax Deduction for Marketing Costs for Drug and Related Businesses
Read the original post.

Letter From Chair and Ranking Republic Member of the Senate Finance Committee
Read the original post.

List of the Blue Dog Democrats in the House
Read the original post.

The Coalition's Letter to Sen. Whitehouse
Read the original post.

The Coalition's Letter to Sen. Franken
Read the original post.

The Coalition's Letter to Sen. Brown
Read the original post.

Slides from July 1, 2009 Special Meeting on Ad Tax
Read the original post.

Proposal to Deny Tax Deduction for Drug Ad Expenses Unconstitutional
Read the original post.

Proposed Limits on Prescription Drug Ads: A Constitutional Analysis
Read the original post.

S. 1763, Ad Tax Bill
Read the original post.

List of Senate Legislative Directors
Read the original post.

"Talking Points" From the Advertising Coalition
Read the original post.

Advertising Coalition to Senators on S. 1763 (2)
Read the original post.

Advertising Coalition to Senators on S. 1763 (1)
Read the original post.

Editorial From AAFP on Pharma Participation in CME
Read the original post.

The Coalition and AAAA's Joint FDA Social Media Testimony
Read the original post.

FDA and Social Media: December 10, 2009 presentation
Read the original post.

MM&M's Profile of Tom Sullivan, Defender of CME
Read the original post.

Digitas Facebook Alert Aug2010
Read the original post.